PriceTargets.com logo

Merck KGaA - MKGAY Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$38.36 As of 08/1/2017 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for MKGAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Merck KGaA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MKGAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MKGAY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Merck KGaA in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $38.36.

This chart shows the closing price for MKGAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Merck KGaA. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/21/2023CitigroupUpgradeNeutral ➝ Buy
7/14/2023HSBCInitiated CoverageBuy
7/6/2023Stifel NicolausInitiated CoverageBuy
2/2/2023CitigroupDowngradeBuy ➝ Neutral
1/6/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight
12/14/2022UBS GroupUpgradeNeutral ➝ Buy
11/14/2022Bank of AmericaUpgradeNeutral ➝ Buy
7/25/2022Jefferies Financial GroupInitiated CoverageBuy
3/14/2022JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight€270.00 ➝ €250.00
2/28/2022UBS GroupUpgradeSell ➝ Neutral
12/6/2021Exane BNP ParibasUpgradeNeutral ➝ Outperform€255.00
11/12/2021Credit Suisse GroupReiterated RatingOutperform
11/12/2021Morgan StanleyReiterated RatingEqual Weight
11/12/2021JPMorgan Chase & Co.Reiterated RatingOverweight
10/19/2021BarclaysUpgradeEqual Weight ➝ Overweight
9/14/2021UBS GroupDowngradeNeutral ➝ Sell
7/9/2021DZ BankDowngradeBuy ➝ Hold
4/14/2021HSBCDowngradeHold ➝ Reduce
2/10/2021Berenberg BankInitiated CoverageHold
1/4/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
11/20/2020Pareto SecuritiesUpgradeHold ➝ Buy
11/16/2020AlphaValueUpgradeReduce
10/13/2020BarclaysUpgradeUnderweight ➝ Equal Weight
9/21/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
9/8/2020Bank of AmericaUpgradeNeutral ➝ Buy
5/15/2020Nord/LBDowngradeBuy ➝ Hold
12/2/2019The Goldman Sachs GroupInitiated CoverageSell
6/28/2019Bank of AmericaDowngradeNeutral ➝ Underperform
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
10/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Merck KGaA logo
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Read More

Today's Range

Now: $38.36
Low: $38.36
High: $38.36

50 Day Range

MA: $38.36
Low: $38.36
High: $38.36

52 Week Range

Now: $38.36
Low: $32.53
High: $42.02

Volume

N/A

Average Volume

6,872 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Merck KGaA?

The following Wall Street analysts have issued research reports on Merck KGaA in the last twelve months: Citigroup Inc., HSBC Holdings plc, and Stifel Nicolaus.
View the latest analyst ratings for MKGAY.

What is the current price target for Merck KGaA?

0 Wall Street analysts have set twelve-month price targets for Merck KGaA in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Merck KGaA in the next year.
View the latest price targets for MKGAY.

What is the current consensus analyst rating for Merck KGaA?

Merck KGaA currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MKGAY will outperform the market and that investors should add to their positions of Merck KGaA.
View the latest ratings for MKGAY.

What other companies compete with Merck KGaA?

Other companies that are similar to Merck KGaA include Acacia Pharma Group, ECO Animal Health Group, 180 Life Sciences, 1933 Industries and 3SBio. Learn More about companies similar to Merck KGaA.

How do I contact Merck KGaA's investor relations team?

The company's listed phone number is 496151720. Learn More about contacing Merck KGaA investor relations.